Historial de carrera de J. Henri Bayle
Antiguos cargos conocidos de J. Henri Bayle.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/01/2014 | 01/03/2023 |
Formación de J. Henri Bayle.
| Princeton University | Doctorate Degree |
| University of Alberta | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Canadá | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- J. Henri Bayle
- Experiencia
